Dr. Andrew Brenner, MD, PhD
Claim this profileUniversity of Texas Health Science Center at San Antonio
Studies Glioblastoma
Studies Gliosarcoma
9 reported clinical trials
19 drugs studied
Area of expertise
1Glioblastoma
Stage IV
IDH negative
Stage III
2Gliosarcoma
Stage I
Stage II
MET negative
Affiliated Hospitals
Clinical Trials Andrew Brenner, MD, PhD is currently running
Multiple Therapies
for Glioblastoma
This trial is testing various treatments for patients with newly diagnosed or returning brain cancer. It adjusts treatments based on how well patients are doing to find the most effective options. The goal is to improve survival rates by matching the best treatments to specific patient types.
Recruiting1 award Phase 2 & 310 criteria
Rhenium-186 NanoLiposomes
for Brain Tumor
This is an open-label, multicenter, Phase 1 study to establish the safety and efficacy/tolerability of a single dose of 186RNL by the intraventricular route (via intraventricular catheter) for recurrence glioma in patients who received a prior treatment of 186RNL.
Recruiting1 award Phase 13 criteria
More about Andrew Brenner, MD, PhD
Clinical Trial Related6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Andrew Brenner, MD, PhD has experience with
- 186RNL
- Bevacizumab
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- Ipilimumab
- Nivolumab
- Radiation Therapy
Breakdown of trials Andrew Brenner, MD, PhD has run
Glioblastoma
Leptomeningeal Metastasis
Leptomeningeal Carcinomatosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Brenner, MD, PhD specialize in?
Andrew Brenner, MD, PhD focuses on Glioblastoma and Gliosarcoma. In particular, much of their work with Glioblastoma has involved Stage IV patients, or patients who are IDH negative.
Is Andrew Brenner, MD, PhD currently recruiting for clinical trials?
Yes, Andrew Brenner, MD, PhD is currently recruiting for 4 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Andrew Brenner, MD, PhD has studied deeply?
Yes, Andrew Brenner, MD, PhD has studied treatments such as 186RNL, Bevacizumab, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging.
What is the best way to schedule an appointment with Andrew Brenner, MD, PhD?
Apply for one of the trials that Andrew Brenner, MD, PhD is conducting.
What is the office address of Andrew Brenner, MD, PhD?
The office of Andrew Brenner, MD, PhD is located at: University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 United States. This is the address for their practice at the University of Texas Health Science Center at San Antonio.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.